Rilexine Chewable Tablets for Dogs

Virbac Animal Health has introduced Rilexine (cephalexin) Chewable Tablets for Dogs, the first FDA-approved cephalexin designed exclusively for the veterinary market, to aid veterinarians and pet owners in the treatment of secondary superficial bacterial pyoderma caused by susceptible strains of Staphylococcus pseudintermedius. Veterinarians have traditionally relied on human generic formulations of cephalexin, and while clinically effective, these products have significant drawbacks: the capsule most often prescribed does not allow for tailored dosing, there are no veterinary-approved dosing guidelines, and the bitter, metallic taste and strong odor can be difficult to mask, leading to noncompliance and compromised outcomes. Rilexine Chewable Tablets, which have proven palatibility with dogs, are scored and available in three sizes (150 mg, 300 mg and 600 mg), making it easier to tailor dosing for each patient.
3200 Meacham Blvd. Fort Worth, TX 76137
Tel: 800-338-3659